INTRODUCTION
Intimate partner violence (IPV), including physical, sexual, and psychological violence from a current or former intimate partner, is a public health concern affecting 5.3 million women in the USA each year. 1 Experience of IPV is associated with elevated rates of multiple chronic and acute physical and mental health conditions, [2] [3] [4] [5] [6] as well as social health needs (e.g., housing, employment), [7] [8] [9] and healthcare use and costs. [10] [11] [12] [13] [14] Healthcare encounters, whether specifically related to IPV health impacts or not, present opportunities to both identify and provide patients with support related to IPV and its aftermath. Women experiencing IPV may be able to safely attend healthcare visits, especially in primary care, without suspicion from an abusive partner or stigma associated with seeking social services. The healthcare encounter offers a chance for trained healthcare personnel to assist patients experiencing IPV through supportive counseling, validation of their experiences, education, and information about and linkages to resources to promote their safety and recovery. Accordingly, IPV screening and response have been recommended for primary care and emergency department encounters, as well as in mental health, obstetrics/gynecology, pediatric, and dental care settings. [15] [16] [17] [18] [19] [20] [21] [22] [23] Women veterans face higher rates of lifetime IPV exposure compared to women who have not served in the military.
Nearly one in five women veterans enrolled in primary care through the Veterans Health Administration (VHA) experience IPV within a single year 24 and one in 12 disclose pastyear IPV to VHA healthcare providers in response to clinical screening. 25 The VHA has recently implemented routine screening of female patients for experience of past-year IPV using the Extended-Hurt, Insult, Threaten, Scream (E-HITS) scale, 26 which asks about frequency of psychological, physical, and sexual violence perpetrated by a current or former intimate partner in the past 12 months. This screening, conducted primarily in primary care but with variation in administration across sites, is used to identify patients experiencing IPV and offer follow-up assessment and intervention services within VHA or community agencies as appropriate.
In this study, we examined electronic health record data (retrospective chart review) to examine the relationship between IPV exposure and healthcare service use among a large cohort of female VHA patients screened for experience of past-year IPV within the context of routine care. This study extends prior research on this relationship [10] [11] [12] [13] to the VHA setting and patient population, and compensates for limitations of prior studies that relied on research survey participation 13 or ad hoc documentation of spontaneous disclosures in healthcare records. 14, 23, 24 As VHA is a nationwide integrated healthcare system, use of electronic health record data allows for analysis of a large sample from sites across the country and inclusion of primary, specialty, mental health, and emergency outpatient and inpatient care. The specific objectives of this study were to (a) compare service utilization in the 6 months following IPV screening between those screening positive and negative for past year IPV (IPV+ vs. IPV−) and (b) examine the types of healthcare services women who have experienced IPV are accessing following disclosure of IPV experience through routine screening. Analysis of these data provides information about potential resource needs for patients experiencing recent IPV, as well as opportunities for further intervention among this patient population.
METHODS
Data were extracted from the VHA Corporate Data Warehouse, a repository of VHA electronic health records aggregated from all VHA facilities nationwide, for all female VHA patients who had documentation of a completed IPV screening using the E-HITS screening tool 26 in their electronic health record between April 2014 and April 2016. The study was approved by the Corporal Michael J. Crescenz VA Medical Center institutional review board, including a waiver of informed consent.
Measures
Demographic characteristics at the time of IPV screening were extracted from electronic health records and included age, race, ethnicity (Hispanic/Latina or not), marital status, and veteran status (some VHA facilities provide care to nonveteran spouses or dependents of eligible veterans). IPV status was defined by routine screening using the E-HITS measure. The E-HITS includes five items, each with a five-point Likert scale, with points ranging from 1 (Bnever^) to 5 (Bfrequently^) and sum scores ranging from 5 to 25. A score of 7 or higher is considered positive for past-year IPV. 27 For women who had multiple IPV screenings documented in the health records, we defined the index screen as the first positive screen or, if no positive screens, the first screen. Health services use data were determined based on Bstop codes,^numeric identifiers for each patient encounter. Stop codes were categorized into types of services: psychosocial (including mental health, drug or alcohol treatment, and social services), primary care, emergency department, other outpatient (i.e., specialty care), and any inpatient admission.
Analysis
We summarized demographic characteristics and health service use within 6 months following IPV screening of the study cohort overall and by IPV status (IPV+, IPV−) groups using frequencies and corresponding percentages. For women screening IPV+, we summarized visit frequencies for each health service type within 14, 30, 60, and 180 days following screening, not including the encounter in which screening occurred but including additional encounters on the same day of screening.
We compared service utilization (yes/no for each category of healthcare visits) between women screening IPV+ and those screening IPV− using chi-square tests and the median number of visits among IPV+ and IPV− women using Wilcoxon non-parametric tests. For patients who had at least one visit, we calculated the median number of visits and interquartile range.
We employed a zero inflated Poisson (ZIP) model as our primary analytical approach to examine the relationship between IPV status and visit frequencies for each health service type. ZIP regression is used to model count data that has an excess (e.g., more than would be expected from a typical Poisson process) of zero counts. Statistical theory suggests that the excess zeros are generated by a separate, independent process; as such, ZIP models have two parts: (1) a typical Poisson count model and (2) a logistic model for the excess zeros. For the Poisson part of the model, we considered IPV status (positive/negative) as the primary exposure of interest in estimating the association with the number of visits (a count) within 6 months following the index IPV screen for each health service type. Similarly, the logistic part of the mixture model estimates the probability of having no visit (e.g., excess zero yes/no) for each respective health service type in the 6 months following IPV screening. Model estimates are presented as odds ratios (ORs) and corresponding 95% confidence intervals (CIs) for the logistic part of the model and as rate ratios (RRs) and corresponding 95% CIs for the Poisson part of the model. These models also account for the potential clustering by VA facility and were fit using the NLMIXED procedure in SAS (version 9.4; SAS Institute Inc.).
We fit two models for each health service type. The first ZIP model included our primary exposure of interest only, IPV status. Next, we further adjusted ZIP models for age, race, marital status, and veteran status as these are factors known to be associated with variation in VHA healthcare use. 28 All analyses were performed using SAS software (version 9.4; SAS Institute Inc.).
RESULTS

Sample Description
The sample included 8888 female patients, 774 (8.7%) of whom screened positive for past-year IPV experience (IPV+). Table 1 presents demographic characteristics and healthcare service use within 6 months following the index IPV screen, for the sample overall and by IPV status (note: comparisons of demographic characteristics by IPV status are available for this sample in a previous publication). 25 About half of the patients in the sample were under age 45 years, with a larger proportion of younger patients in the IPV+ group. Just over half of the sample was identified as White, and approximately 90% was identified as not Hispanic or Latina; approximately one third were married. Nonveterans (5.2%) included patients eligible for VHA due to their relationship as a spouse or veteran of eligible veteran.
The overwhelming majority (91.8%) of all patients returned for an outpatient encounter within 6 months following the index IPV screen. Just under half (47.7%) of IPV− patients and three-quarters (74.9%) of IPV+ patients had a psychosocial encounter within this time frame. Close to 70% of IPV− and 75% IPV+, patients had a primary care encounter. Approximately one in five IPV− patients and more than one in four IPV+ patients had an emergency department encounter in the 6 months following IPV screening. Four percent of IPV− patients and 7.1% of IPV+ patients received inpatient care within the study time frame. Among those with any outpatient encounter during the 6 months following IPV screening, the median number of encounters was 7 for the IPV− group (IQR = 3, 14) and 11 for the IPV+ group (IQR = 5, 20).
Visit Frequency by IPV Status
In both unadjusted and adjusted models, patients screening IPV+ were nearly twice as likely as those screening IPV− to receive any outpatient services and more than three times as likely as those screening IPV− to receive any psychosocial care within 6 months following IPV screening ( Table 2 ). Odds of having any primary care visit within the 6-month period post-screening were also higher among the IPV+ versus IPV− group, and when adjusting for demographic characteristics (age, race, marital status, veteran status), women screening IPV+ were also more likely than those screening IPV− to have an inpatient stay in the 6 months following IPV screening.
When examining the number of visits within the 6-month time frame, among those with any visits, the IPV+ group had higher frequency of service utilization compared with the IPV− group for each category of outpatient visits. Among those with any psychosocial encounters in the 6-month period, the IPV+ group had approximately 50% more visits than the IPV− group. There was no statistically significant difference between the two groups in frequency of inpatient stays.
Service Utilization Among IPV+ Patients Figure 1 demonstrates the proportion of IPV+ patients who received each type of service within: 14, 30, 60, and 180 days of the index IPV screen. Within 2 weeks (14 days) of the positive IPV screen, 70.9% of IPV+ patients had an additional outpatient visit beyond the visit in which they were screened, 46.1% had an encounter with a mental or behavioral health provider (psychosocial encounter), and 19.6% had a primary care visit. Nearly 4% of IPV+ patients had a visit to the emergency department within 2 weeks of the IPV screen; this proportion jumped to 8% within 1 month (30 days), 14.5% within 2 months, and 26.7% by 6 months.
DISCUSSION
This study presents new findings regarding health service utilization patterns following IPV screening in a routine clinical care setting among a large cohort of female patients. These findings indicate that the overwhelming majority of women in the VHA healthcare system who screen positive for IPV return for outpatient visits within a brief time frame following the screening visit (> 70% within 14 days and > 95% within 6 months), providing opportunities to offer follow-up support for IPV-related needs.
The positive association between screening positive for past-year IPV and increased health services use is consistent with prior literature 10, 13, 14 and may be attributed to multiple factors. Women experiencing IPV may be more likely to utilize healthcare services due to IPV-related healthcare needs, such as physical or psychological effects of IPV exposure. A positive IPV screen may also prompt providers to offer or encourage follow-up care to address IPV-related needs, although we are unable to assess from this study whether or not those return visits indeed were used to address IPV. Additionally, women who have experienced IPV have emphasized the importance of feeling comfortable with a provider as a prerequisite to disclosing IPV experience 29, 30 ; thus, those who have more frequent healthcare visits may be more comfortable and familiar with their providers, facilitating such disclosure.
Return outpatient visits following the visit during which the patient was screened offer opportunities for follow-up support and intervention. The fact that over 70% of patients screening IPV+ returned to a VHA provider within 2 weeks of a positive screen supports the feasibility of offering in-person follow-up services related to IPV. Although these return visits may not (and likely are not) all specifically in response to IPV screening, the fact that patients do return provides an opportunity for providers to check in with patients about IPV, offer resources or referrals, or conduct more formal or structured intervention. Such interventions may include in-depth assessment and safety planning, psychoeducational programming, counseling, and connection to community-based services. That three quarters of the women who disclosed recent IPV experience received psychosocial care indicates high levels of access to services that may be appropriate for follow-up care. These may include both social services (e.g., housing support) and mental health treatment. Such services may lead to improved safety and health among women who experience IPV. 33 We do not know from these data, however, if IPV experiences were addressed in these encounters or if these visits occurred because of the IPV screening response (i.e., patients referred to psychosocial support in response to IPV).
Emergency department visits among women screening IPV+ may provide an opportunity for emergency-based and brief interventions and may also indicate an IPV-related injury or crisis. Prior research has found elevated rates of emergency department use among women experiencing IPV and identified the emergency department as a primary intervention point for IPV-related concerns. 31, 32 This is the first study to examine healthcare service use among patients experiencing IPV utilizing health records data within the VHA healthcare system. Analysis of health records data from this system and population offers several unique contributions. Unlike prior studies of healthcare service utilization among women experiencing IPV, [10] [11] [12] [13] [14] this study (a) is not reliant on enrollment in or responses to research surveys; (b) examines healthcare utilization within an integrated system including mental, behavioral, and social health services; and (c) examines responses to routine healthcare screening for experience of recent (past-year) IPV. The VHA healthcare setting offers unique opportunities to study a large cohort of patients across the nation and service utilization across a variety of healthcare services (psychosocial, primary, specialty, emergency, and inpatient care).
This cohort only included patients currently receiving care at a VHA facility, which limits the generalizability of findings across populations and settings. Patients not served in the VHA may differ from those included in this study in both their healthcare service access and needs. Psychosocial care may be less readily available in a less-or non-integrated healthcare system. Additionally, this study focused only on VHA service use and does not capture service use or informal systems of support that women may have received outside of the VHA system. Analyses were limited to data available in the electronic health record and thus do not include all potential confounders of health services use such as patient attitudes, barriers to access, and additional sociodemographic characteristics. Further research identifying the full range of resources and supports utilized by women who screen positive for recent IPV is important to inform the needs and resources available to this population.
Next steps for research include gaining a better understanding of the focus of subsequent health service use and the impact of service use on patient health and functioning outcomes, including safety, health, and well-being over time. Additionally, future research should examine whether followup visits actually address IPV, in what ways, and the kinds of interventions that are useful to patients following disclosure of IPV in the healthcare setting.
